Stifel reiterates Buy on Ligand Pharma stock, $332 target
Reported by Investing.com · investing.com ·
Story context
What to watch: This report cites a concrete figure ($332) — compare it against the trailing trend before treating one data point as a turning point.
Latest session change: $LGND -0.99%
How this was labelled
Investing.com published it, and Wook filed it under Healthcare & Pharma. No strongly worded term either way, so it reads neutral at low severity — a factual headline rather than a charged one. It was matched to $LGND. It carried $332, shown as published and not recalculated. The publisher gave no preview text, and nothing has been written in to fill the gap.
When it landed
It landed before the opening bell; the next session was the first that could react.
Where the price is
$LGND last traded at $295.54, -0.99% on the session. That is 9.5% below its 52-week high of $326.63 and 68% above its low of $175.89 — in the upper part of the range. The year's range spans 86% from low to high: a wide band — moves of several percent in a week are ordinary at that volatility. These are latest-session quotes, not live prices.
The backdrop
Healthcare stories tend to turn on approvals, trial data and pricing: an FDA decision or a trial readout can move a single drugmaker sharply, while drug-pricing policy moves the whole group. On Wook's supply-chain scanner, Health Care reads calm today — no unusual stress in the filings and disclosures it reads.
What is already on the calendar
$LGND earnings in 12 days. These were scheduled before this story and are not caused by it, but the nearest is close enough that the next hard numbers on this company will arrive soon.
Where to look next
The $LGND page has the full chart, the filings and the valuation model behind these figures. Comparing how two or three outlets frame the same story is the quickest way to separate the facts from the angle. Wook AI, above, can pull live figures and do the math — how far $LGND is from its high, or how this week's coverage compares — on request.
What this page is not saying
The tone and severity labels come from a fixed word list — no editor, no AI — so they describe how a story is worded, not what happens next. They are not a forecast or a recommendation, and a same-day move does not mean this story caused it. Not investment advice.
Discussion
No one has weighed in yet. Start the discussion on this story.
What happened after this published
Investing.com published this on August 14, 2026. $LGND has moved +0.32% ($294.60 to $295.54). Measured from the first print available after publication, against the latest available quote. This comparison does not isolate the story's effect.